Tolerability and pharmacokinetics of oxaloacetate 100 mg capsules in Alzheimer's subjects

about

Oxaloacetate induces apoptosis in HepG2 cells via inhibition of glycolysis.Oxaloacetate Ameliorates Chemical Liver Injury via Oxidative Stress Reduction and Enhancement of Bioenergetic Fluxes.

P2860

Q52658483-70567565-D630-4FD8-9C65-2EAE0D10F5AB Q54977377-E3C4A7A3-89D2-4F08-A762-B2A441DFA8E1

P2860

Tolerability and pharmacokinetics of oxaloacetate 100 mg capsules in Alzheimer's subjects

Item

http://www.wikidata.org/entity/Q36751377

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Tolerability and pharmacokinetics of oxaloacetate 100 mg capsules in Alzheimer's subjects

@en

type

Item

label

Tolerability and pharmacokinetics of oxaloacetate 100 mg capsules in Alzheimer's subjects

@en

prefLabel

Tolerability and pharmacokinetics of oxaloacetate 100 mg capsules in Alzheimer's subjects

@en

P1476

Tolerability and pharmacokinetics of oxaloacetate 100 mg capsules in Alzheimer's subjects

@en

P2093

Gregory A Reed

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Burns

http://www.w3.org/2001/XMLSchema#string

Lewis Hutfles

http://www.w3.org/2001/XMLSchema#string

Rebecca Bothwell

http://www.w3.org/2001/XMLSchema#string

Russell H Swerdlow

http://www.w3.org/2001/XMLSchema#string

P2860

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Pathogenesis of Alzheimer's disease

Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.

Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.

The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

Bioenergetic medicine.

Oxaloacetate: a novel neuroprotective for acute ischemic stroke.

Oxaloacetate enhances neuronal cell bioenergetic fluxes and infrastructure.

Derivatization of the tricarboxylic acid intermediates with O-benzylhydroxylamine for liquid chromatography-tandem mass spectrometry detection.

Combined Treatment of an Amyotrophic Lateral Sclerosis Rat Model with Recombinant GOT1 and Oxaloacetic Acid: A Novel Neuroprotective Treatment.

P304

120-123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBACLI.2016.03.005

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27051598

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4816034

http://www.w3.org/2001/XMLSchema#string

Tolerability and pharmacokinetics of oxaloacetate 100 mg capsules in Alzheimer's subjects

about

P2860

P2860

Tolerability and pharmacokinetics of oxaloacetate 100 mg capsules in Alzheimer's subjects

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932